Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE638079DpriorityCriticalpatent/BE638079A/fr
Application filed by Merck and Co IncfiledCriticalMerck and Co Inc
Priority to FR949118Aprioritypatent/FR1383836A/fr
Application grantedgrantedCritical
Publication of FR1383836ApublicationCriticalpatent/FR1383836A/fr
C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07J—STEROIDS
C07J75/00—Processes for the preparation of steroids in general
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
Health & Medical Sciences
(AREA)
General Health & Medical Sciences
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
FR949118A1963-09-301963-09-30Composés de gona-4, 8(14),-9-triène-3, 17-diones et leurs procédés de fabrication
ExpiredFR1383836A
(fr)